Personalized Medicine, Big Companies to Lead MedTech Growth to 2018

In vitro diagnostics (IVD) could claim the lion’s share of a $440 billion global medtech market in 2018, thanks to the rise of personalized medicine, a new report by London consulting group EvaluateMedTech says. The IVD market is expected to grow 4.4 percent annually over the next six years — keeping pace with growth in medtech overall and nearly doubling the 2.5 percent anticipated growth in prescription drugs.
Devices & Diagnostics Letter